Artivion (AORT) Assets Average (2011 - 2026)
Artivion's (AORT) quarterly Assets Average came in at $977.5 million in Q2 2026, up 19.98% on a YoY basis from $814.8 million in Q2 2025, and up 10.59% quarter-over-quarter from $884.0 million in Q1 2026.
Analysis
Artivion (AORT) Assets Average (2011 - 2026) Analysis & Trends
Artivion (AORT) has reported Assets Average for 16 consecutive years, with $977.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average rose 19.98% year-over-year to $977.5 million; the trailing twelve-month figure through Jun 2026 stood at $977.5 million (up 19.98% YoY), and the FY2025 full-year result was $836.9 million, up 5.84% from the prior year.
- Assets Average grew to $977.5 million in Q2 2026 per AORT's latest filing, from $884.0 million in the prior quarter.
- Across five years, Assets Average topped out at $977.5 million in Q2 2026 and bottomed at $752.8 million in Q4 2022.
- Historically, Assets Average has averaged $806.0 million across 5 years, with a median of $787.8 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Assets Average declined 7.46% in 2022, then grew 19.98% in 2026.
- Over 5 years, Assets Average stood at $752.8 million in 2022, then climbed by 4.1% to $783.6 million in 2023, then climbed by 1.6% to $796.1 million in 2024, then advanced by 9.43% to $871.2 million in 2025, then climbed by 12.2% to $977.5 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $977.5 million, $884.0 million, and $871.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 20.49 Bn |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 93.17 Bn |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | 47.11 Bn |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | 44.78 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | 13.59 Bn |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | 31.36 Bn |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 6.54 Bn |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Artivion | 1.22 Bn | 1.14 Bn | 80.52 Mn | 977.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 977.55 Mn |
| Mar 31, 2026 | 883.98 Mn |
| Dec 31, 2025 | 871.23 Mn |
| Sep 30, 2025 | 848.02 Mn |
| Jun 30, 2025 | 814.78 Mn |
| Mar 31, 2025 | 790.13 Mn |
| Dec 31, 2024 | 796.12 Mn |
| Sep 30, 2024 | 796.34 Mn |
| Jun 30, 2024 | 786.77 Mn |
| Mar 31, 2024 | 788.20 Mn |
| Dec 31, 2023 | 783.59 Mn |
| Sep 30, 2023 | 776.32 Mn |
| Jun 30, 2023 | 767.47 Mn |
| Mar 31, 2023 | 759.94 Mn |
| Dec 31, 2022 | 752.76 Mn |
| Sep 30, 2022 | 753.80 Mn |
| Jun 30, 2022 | 773.36 Mn |
| Mar 31, 2022 | 787.45 Mn |
| Dec 31, 2021 | 805.85 Mn |
| Sep 30, 2021 | 814.58 Mn |